Bosh sahifaTWST • NASDAQ
add
Twist Bioscience Corp
36,94 $
Seans yopilganidan keyin:(0,00%)0,00
36,94 $
Yopilgan:26-iyn, 16:10:10 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
36,99 $
Kunlik diapazon
36,08 $ - 37,48 $
Yillik diapazon
27,12 $ - 60,90 $
Bozor kapitalizatsiyasi
2,21 mlrd USD
Oʻrtacha hajm
1,17 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 92,79 mln | 23,23% |
Joriy xarajat | 87,59 mln | 9,80% |
Sof foyda | -39,33 mln | 13,55% |
Sof foyda marjasi | -42,38 | 29,85% |
Har bir ulushga tushum | -0,66 | 16,46% |
EBITDA | -35,16 mln | 13,38% |
Amaldagi soliq stavkasi | -0,45% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 257,15 mln | -12,34% |
Jami aktivlari | 595,62 mln | -15,26% |
Jami passivlari | 155,51 mln | 8,96% |
Umumiy kapital | 440,11 mln | — |
Tarqatilgan aksiyalar | 59,92 mln | — |
Narxi/balansdagi bahosi | 5,03 | — |
Aktivlardan daromad | -17,26% | — |
Kapitaldan daromad | -19,62% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -39,33 mln | 13,55% |
Operatsiyalardan naqd pul | -12,99 mln | 33,14% |
Sarmoyadan naqd pul | -1,43 mln | 72,79% |
Moliyadan naqd pul | 3,20 mln | 74,84% |
Naqd pulning sof oʻzgarishi | -11,11 mln | 51,48% |
Boʻsh pul | -5,15 mln | 14,52% |
Haqida
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Tashkil etilgan
2013
Xodimlar soni
923
